Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DWP450 vs Botox in Post-Stroke Upper Limb Spasticity
NCT01945684Phase 3Completed
- Sponsor
- Daewoong Pharmaceutical
- Start
- Sep 2013
- Primary completion
- May 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of prabotulinumtoxinA in spasticity (2 arms), sponsored by Daewoong Pharmaceutical. Primary endpoint: Change in Modified Ashworth Scale grade for Wrist flexor at 4 weeks. Started Sep 2013; status: completed.
02
Drugs
prabotulinumtoxinA
03
Conditions
spasticity
Beyond the preview
Go deeper on NCT01945684.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01945684.